Clinical trial
Investigation of the Effects of Omega-3 Supplementation in Chronic Kidney Disease Patients Diagnosed With Coronary Artery Disease and Dyslipidemia
NCT07127068 is registered in ClinicalTrials.gov with University of Beykent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Effects of Omega-3 Supplementation in Chronic Kidney Disease Patients Diagnosed With Coronary Artery Disease and Dyslipidemia
- Lead sponsor
- University of Beykent
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 1, 2024
- Completion date
- November 20, 2025
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease(ckd), coronary arterial disease (cad), omega 3 fatty acids